Researcher
Hans Van Vlierberghe
- Keywords:liver transplantation, hepatocellular carcinoma, liver diseases
- Disciplines:Cancer diagnosis, Cancer prevention, Cancer epidemiology, Cancer biology, Cancer therapy, Gastro-enterology and hepatology not elsewhere classified, Hepatology (incl. pancreas), Oncology not elsewhere classified, Gastro-enterology, Hepatology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Oct 2003 → 30 Sep 2018
Projects
1 - 10 of 19
- Development of cell-interactive and biodegradable AUP-based hydrogel materials for the fabrication of three-dimensional liver tissue engineering scaffoldsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Optimising the Human Detection of Cancer within Colorectal Polyps with a Simple Clinical AlgorithmFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Deubiquitinase UCHL1 targeting as part of new combinatorial treatments for hepatocellular carcinoma: a preclinical assessmentFrom1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- The role of Kupffer cells in the pathogenesis of hepatocellular carcinoma.From1 Nov 2021 → 31 Oct 2022Funding: Nonprofit institution or equivalents
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitisFrom1 Nov 2021 → TodayFunding: FWO fellowships
- Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis.From1 Oct 2021 → 31 Oct 2021Funding: BOF - doctoral mandates
- Dual targeting of CCr2 and CCR5 as thearpy for hepatocellular carcinoma: can we break immune tolerance?From1 Oct 2018 → 30 Sep 2022Funding: Nonprofit institution or equivalents
- Replacement of N-glycan analysis equipmentFrom1 Jun 2018 → 31 May 2020Funding: BOF - Other initiatives
- Startersbeurs Helena Degroote: The origin of tumor-associated macrophages and the therapeutic potential of dual targeting CCR2 and CCR5 as therapy for hepatocellular carcinomaFrom1 Oct 2017 → 30 Sep 2018Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 103
- Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis(2024)
Authors: Kevin De Muynck, Lander Heyerick, Federico Francesco De Ponti, Bart Vanderborght, Tim Meese, Sanne Van Campenhout, Leen Baudonck, Eva Gijbels, Pedro M. Rodrigues, Jesus M. Banales, et al.
Pages: 269 - 288 - A remarkable presentation of a massive Budd-Chiari syndrome(2023)
Authors: Helena Degroote, Anja Geerts, Hans Van Vlierberghe, Xavier Verhelst, Sarah Raevens
Pages: 503 - 504 - Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma(2023)
Authors: Bart Vanderborght, Kevin De Muynck, Eva Gijbels, Sander Lefere, Charlotte Scott, Martin Guilliams, Alain Beschin, Mathieu Vinken, Xavier Verhelst, Anja Geerts, et al.
Pages: 2615 - 2628 - An unusual cause of portal hypertension(2023)
Authors: Thibaud Lamiroy, Anne Hoorens, Xavier Verhelst, Helena Degroote, Sarah Raevens, Hans Van Vlierberghe, Anja Geerts
Pages: 509 - 510 - Gelatin-based hybrid hydrogel scaffolds : toward physicochemical liver mimicry(2023)
Authors: Nathan Carpentier, Louis Van der Meeren, Andre Skirtach, Lindsey Devisscher, Hans Van Vlierberghe, Peter Dubruel, Sandra Van Vlierberghe
Pages: 4333 - 4347 - R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation(2022)
Authors: Charlotte Costentin, Federico Pinero, Helena Degroote, Andrea Notarpaolo, Ilka F. Boin, Karim Boudjema, Cinzia Baccaro, Luis G. Podesta, Philippe Bachellier, Giuseppe Maria Ettorre, et al.
- The gut–liver axis in chronic liver disease : a macrophage perspective(2021)
Authors: Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher
- International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria(2021)
Authors: Helena Degroote, Federico Pinero, Charlotte Costentin, Andrea Notarpaolo, Ilka F. Boin, Karim Boudjema, Cinzia Baccaro, Aline Lopes Chagas, Philippe Bachellier, Giuseppe Maria Ettorre, et al.
- Serum glycomics 7 days after liver transplantation relate to graft loss 3 months after liver transplantation independently of early allograft dysfunction(2021)Volume: 105
Authors: Xavier Verhelst, Anja Geerts, Rachel Colman, Luis Filipe Abreu de Carvalho, Roberto Troisi, Frederik Berrevoet, Xavier Rogiers, Nadine Callewaert, Hans Van Vlierberghe, Helena Degroote
Pages: 83 - 83 - Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC)(2020)
Authors: G. Dahlqvist, O. Ciccarelli, Hans Van Vlierberghe, Frederik Berrevoet, T. Vanwolleghem, D. Ysebaert, T. Gustot, V Lucidi, J. Delwaide, O. Detry, et al.
Pages: 340 - 343